Chronic Endometritis and IVF: Silent Inflammation, Biopsy & Treatment
Key Takeaways
Chronic endometritis is a persistent, low-grade inflammation of the uterine lining. It differs from acute endometritis: symptoms may be mild or absent, yet the endometrium may still be less favorable for implantation. Diagnosis usually needs endometrial biopsy with plasma-cell (often CD138) staining — not ultrasound alone.
When silent lining inflammation matters for IVF
Chronic endometritis is a low-grade, persistent inflammation of the uterine lining. It differs from acute endometritis, which is a more abrupt pelvic infection. In the chronic form, immune cells — especially plasma cells — linger in the endometrium. Symptoms may be absent, yet the lining may still be less receptive for implantation.
That silence is why the diagnosis is easy to miss on a routine scan. Ultrasound alone rarely proves it. Confirmation usually needs an endometrial biopsy with plasma-cell staining (often CD138), sometimes after hysteroscopy when the cavity looks uneven or when implantation has failed more than once.
This is why the diagnosis appears in discussions of recurrent implantation failure, recurrent miscarriage, or unexplained infertility. Couples travelling for IVF abroad should bring prior biopsy or hysteroscopy reports when available, so the receiving clinic can decide whether further cavity assessment is needed before transfer.
Why it matters in IVF
Chronic inflammation may alter local immune signalling and the surface of the lining in ways that interfere with implantation or early placental development. Studies link confirmed chronic endometritis with poorer reproductive outcomes in selected groups, especially after repeated failure.
Not every failed IVF cycle is caused by this diagnosis. Not every patient should be screened automatically. When the clinical history raises concern, it becomes a relevant piece of reproductive medicine to evaluate — alongside embryo quality, timing, and other cavity findings.
Why it is easy to miss
Many patients have no clear symptoms. Others may notice:
- irregular bleeding,
- spotting,
- pelvic discomfort,
- unusual discharge.
These signs are nonspecific. They overlap with many benign cycle changes. That is why symptoms alone cannot confirm or exclude chronic endometritis.
Acute endometritis, by contrast, more often presents with fever, marked pain, or recent instrumentation — a different clinical urgency.
How chronic endometritis is diagnosed
Common tools:
| Tool | Role |
|---|---|
| Hysteroscopy | May show micropolyps, focal hyperemia, or stromal edema — clues, not proof |
| Endometrial biopsy | Tissue from the uterine cavity for histology |
| CD138 staining | Highlights plasma cells; used widely to support the diagnosis |
| Culture / microbiology | Sometimes added; practice varies by centre |
A biopsy-based approach is generally more reliable than symptoms or imaging alone. Ultrasound can miss the finding entirely.
When it is usually investigated
Clinicians are more likely to evaluate when there is:
- recurrent implantation failure,
- recurrent pregnancy loss,
- unexplained infertility after a structured workup,
- suspicious hysteroscopic findings inside the cavity.
Routine testing in every first IVF patient remains controversial. The value of screening depends on history, prior transfers, and what else has already been checked. See also hysteroscopy before IVF.
Treatment for chronic endometritis
When the diagnosis is confirmed, treatment often includes antibiotics chosen according to local protocols, culture data when available, and clinical history. Some teams use a combination regimen; others tailor therapy to microbiology.
Many patients undergo a test of cure — a repeat biopsy after treatment — to check whether plasma-cell inflammation has cleared before the next transfer.
Treatment should follow a real diagnosis. Empiric antibiotics for every failed cycle, without biopsy confirmation, are a weaker strategy and can add unnecessary medication.
What treatment does — and does not — promise
Clearing confirmed chronic endometritis may improve the chance of implantation in selected patients. It does not guarantee pregnancy. Embryo genetics, age, sperm factors, and other uterine conditions still matter.
If transfers continue to fail after a documented cure, the team widens the review again rather than repeating the same antibiotic course indefinitely. See failed IVF: what to review next.
Related reading
- How hysteroscopy can help fertility care in selected patients
- Hysteroscopy before IVF: when it helps
- Unexplained infertility: what the diagnosis means
FAQ
Can chronic endometritis be found on ultrasound alone?
Usually not reliably. Ultrasound may raise suspicion in some cases, but diagnosis generally depends on endometrial sampling, often with biopsy and CD138 staining.
Should every IVF patient be tested for chronic endometritis?
No. Routine screening in every patient remains controversial. Evaluation is usually more relevant after repeated implantation failure, recurrent pregnancy loss, unexplained infertility, or suspicious cavity findings.
If chronic endometritis is treated, does IVF success always improve?
Not automatically. Treatment may help when the diagnosis is real and clinically relevant, but it does not explain every failed transfer and should not be framed as a universal fix.
How is chronic endometritis different from acute endometritis?
Acute disease is typically a more abrupt infectious picture. Chronic endometritis is low-grade and often silent, diagnosed by plasma cells in the lining rather than by fever alone.
Do I need antibiotics before every embryo transfer “just in case”?
Not as a default. Antibiotics make more sense after a confirmed diagnosis (and often after documenting clearance), not as a ritual before every transfer.
Sources
- Chronic Endometritis and Reproductive Failure: Review
- ESHRE Good Practice Recommendations on Recurrent Implantation Failure
- StatPearls: Endometritis
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.